CNCR

ETF ticker: NASDAQ

PRICE

CHANGE

NET ASSETS

Range Cancer Therapeutics ETF (CNCR) Ownership - Who owns Range Cancer Therapeutics ETF?

The investment seeks to track the performance, before fees and expenses, of the Range Oncology Therapeutics Index... Show more

Category: #Health

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Details

Group

Domestic Stock Funds

Fundamentals

CNCR

Net Assets

7.56M

Yield

0.00

Fund Existence

over 9 years

Total Expense Ratio

0.79

Turnover

52.00

Investment Style

N/A

Capitalization

N/A

Risk (Beta)

0.92

Manager Tenure

N/A

Administrative Fee

N/A

Annual Report Gross Expense Ratio

0.79

Assets in Top Ten Holdings

4.2M

Average Credit Quality

N/A

Average Effective Duration

N/A

Average Effective Maturity

N/A

Fund of Funds

Fund Share Class Net Assets

7.56M

Fund Type

ETF

Index Fund

Yes

Management Fee

0.79

Modified Duration

N/A

No Load Fund

Yes

Number of Long Holdings

76.00

Number of Net Holdings

77.00

Number of Short Holdings

1.00

Prospectus Acquired Expense Ratio

N/A

Weighting Top Ten Holdings

26.68%

Gain YTD

-19.821

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CNCR (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Category Health

Profile

Fundamentals

Details